Federal Signal Corporation Declares Dividend of $0.12 per share
Federal Signal Corporation Declares Dividend of $0.12 per share
PR Newswire
DOWNERS GROVE, Ill., July 23, 2024
DOWNERS GROVE, Ill., July 23, 2024 /PRNewswire/ -- Federal Signal Corporation (NYSE:FSS) today announced that its Board of Directors declared a quarterly cash dividend of twelve cents ($0.12) per share on its common stock. The dividend is payable on August 30, 2024 to stockholders of record at the close of business on August 16, 2024.
About Federal Signal
Federal Signal Corporation (NYSE: FSS) builds and delivers equipment of unmatched quality that moves material, cleans infrastructure, and protects the communities where we work and live. Founded in 1901, Federal Signal is a leading global designer, manufacturer and supplier of products and total solutions that serve municipal, governmental, industrial and commercial customers. Headquartered in Downers Grove, Ill., with manufacturing facilities worldwide, the Company operates two groups: Environmental Solutions and Safety and Security Systems. For more information on Federal Signal, visit: https://www.federalsignal.com.
View original content:https://www.prnewswire.com/news-releases/federal-signal-corporation-declares-dividend-of-0-12-per-share-302204211.html
SOURCE Federal Signal Corporation
-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks